Randomized Double-Blind Phase 2 Study of Allogeneic HB-adMSCs for the Treatment of Chronic Post-COVID-19 Syndrome
Clinical trial NCT05126563 · COMPLETED
Trial details
- NCT number
- NCT05126563
- Sponsor
- Hope Biosciences Research Foundation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-02
- Primary completion
- 2024-04-02
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.